ONS Annual Congress 2022

Anxiety Level, Symptom Burden Linked in Gynecologic Cancers

Researchers described distinct anxiety profiles and identified clinical characteristics of each one.

Validation of Nursing Skills Improves Central Line Infection Rates on HSCT Unit

A project to reverse an increase in CLABSIs on an HSCT inpatient unit and its ongoing impact were described at the Annual ONS Congress.

Engaging Patients to Improve Genetic Risk Assessment and Testing

Preliminary results of a study comparing outreach methods for engaging patients in genetic risk assessment and testing are presented.

Overcoming Pandemic-Based Barriers to Nutritional Risk Assessment of Patients

An internal focus group produced a process to overcome the barriers to nutritional risk assessment of patients with cancer.

Task Force Improves Mediport Infection Rates in Ambulatory Patients With Cancer

A plan for reducing mediport infections in ambulatory patients was described at the 2022 ONS Congress.

Coordinating Intravenous Site Selection for Same-Day Imaging and Chemotherapy

A team of nurses sought to improve coordination of care regarding choice of insertion site for peripheral intravenous catheters in patients undergoing same-day imaging and chemotherapy.

Addressing Fertility Risks and Preservation in Adolescent and Young Adult Patients With Cancer

The interventions developed to address barriers to fertility discussions with AYA patients at a major cancer center are described.

Colorectal Cancer Treatment Has Long-Term Cognitive, Functional Effects on Survivors

Researchers sought to confirm several hypotheses regarding long-term effects of treatment in patients with colorectal cancer.

Health-Promoting Behaviors: A Measure of Caregiver Burden in the Cancer Setting

Researchers sought to classify health-promoting behavior levels among family caregivers of patients with cancer and to identify risk factors for low levels.

SOP for Successful Administration of Immune Effector Cell Therapy

An SOP for the administration of investigational immune effector cell therapy was established and presented at ONS Congress 2022.

Potential of Cannabis, Cannabinoid Products in Managing Cancer Symptom Burden

Researchers conducted a literature search for evidence of the effects of medical marijuana products on symptom burden in patients with cancer.

Benefits of Survivorship Clinic Outweigh Potential Costs

Poster presentation details the benefits of a survivorship clinic and how they exceed the costs of the program.